Zoetis/$ZTS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Zoetis
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Ticker
$ZTS
Sector
Primary listing
NYSE
Industry
Pharmaceuticals
Headquarters
Employees
13,800
Website
Zoetis Metrics
BasicAdvanced
$65B
26.17
$5.57
0.94
$1.86
1.37%
Price and volume
Market cap
$65B
Beta
0.94
52-week high
$194.42
52-week low
$139.70
Average daily volume
3.2M
Dividend rate
$1.86
Financial strength
Current ratio
1.736
Quick ratio
0.916
Long term debt to equity
116.455
Total debt to equity
145.628
Dividend payout ratio (TTM)
32.25%
Interest coverage (TTM)
15.56%
Profitability
EBITDA (TTM)
3,867
Gross margin (TTM)
70.96%
Net profit margin (TTM)
27.12%
Operating margin (TTM)
37.02%
Effective tax rate (TTM)
20.90%
Revenue per employee (TTM)
$670,000
Management effectiveness
Return on assets (TTM)
15.11%
Return on equity (TTM)
52.09%
Valuation
Price to earnings (TTM)
26.172
Price to revenue (TTM)
7.09
Price to book
13.97
Price to tangible book (TTM)
75.88
Price to free cash flow (TTM)
28.864
Free cash flow yield (TTM)
3.46%
Free cash flow per share (TTM)
5.051
Dividend yield (TTM)
1.28%
Forward dividend yield
1.37%
Growth
Revenue change (TTM)
6.32%
Earnings per share change (TTM)
7.32%
3-year revenue growth (CAGR)
5.58%
10-year revenue growth (CAGR)
6.84%
3-year earnings per share growth (CAGR)
8.52%
10-year earnings per share growth (CAGR)
16.79%
3-year dividend per share growth (CAGR)
18.66%
10-year dividend per share growth (CAGR)
19.64%
What the Analysts think about Zoetis
Analyst ratings (Buy, Hold, Sell) for Zoetis stock.
Zoetis Financial Performance
Revenues and expenses
Zoetis Earnings Performance
Company profitability
Zoetis News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept3
Zoetis
Dividend·Payment
$0.50Per share
FAQs
What’s the current market cap for Zoetis stock?
Zoetis (ZTS) has a market cap of $65B as of August 01, 2025.
What is the P/E ratio for Zoetis stock?
The price to earnings (P/E) ratio for Zoetis (ZTS) stock is 26.17 as of August 01, 2025.
Does Zoetis stock pay dividends?
Yes, the Zoetis (ZTS) stock pays dividends to shareholders. As of August 01, 2025, the dividend rate is $1.864 and the yield is 1.37%. Zoetis has a payout ratio of 32.25% on a trailing twelve-month basis.
When is the next Zoetis dividend payment date?
The next Zoetis (ZTS) dividend payment is scheduled for September 03, 2025.
What is the beta indicator for Zoetis?
Zoetis (ZTS) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.